CERBIOS PROVIDES CDMO SERVICE FOR CLINICAL AND COMMERCIAL SUPPLY
Cerbios-Pharma SA is a private owned self-financed pharmaceutical company headquartered in Lugano (Switzerland) with more than 40 years of experience in the pharmaceutical industry, active in the field of APIs, HPAPIs, ADCs and Biotechnology.
Cerbios offers CDMO services for ADCs, HPAPIs and Recombinant Proteins. Moreover, Cerbios expands its services portfolio through PROVEO (a division of Cerbios-Pharma SA) that provides a fully integrated end-to-end CDMO service for ADCs, from cell line development and mAbs, up to linker-payload, conjugation and aseptic filling, from clinical to commercial stages.
Type: Service / Capability Showcase
Category:
CMC: Biologics, Drug Substance
CMC: Biologics, Analytical
CMC: Small Molecules, Drug Substance
CMC: Small Molecules, Analytical
Hashtags: #adc, #asepticfilling, #asepticmanufacturing, #bioconjugation, #cdmo, #cdmoadc, #cdmohpapi, #cdmosmallmoleculeadc, #cerbios, #clinicalmanufacturing, #commercialmanufacturing, #commercialsupplies, #end2end, #environment, #hpapi, #hpapis, #integration, #linkerpayload, #mab, #proveo, #sustainability
BIO2BUSINESS LTD. London BioScience Innovation Centre, 2 Royal College Street, London. NW1 0NH.
Contact us by phone on +44 (0)207 691 3568; or by e-mail at [email protected]
Bio2BEvents Home | BOS Media pack for 2024 events
